In a recently published experience, ten patients with R/R T-cell malignancies, including one patient with angioimmunoblastic T-cell lymphoma (AITL) and one with mycosis fungoides, were treated with anti-CD7 autologous and allogeneic CAR-T cells. This evidence concerns the gene CD7 and angioimmunoblastic T-cell lymphoma.